Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01343316 · ClinicalTrials.gov registry record
Benefits of Post-Pyloric Feeding Tubes in Critically Ill Patients
A clinical trial, sponsored by Johns Hopkins University.
- Terminated
- Registry status
- 21
- Enrollment target
NCT01343316: Clinical Trial study, sponsored by Johns Hopkins University.
NCT01343316 is a clinical trial that was terminated before completion, run by Johns Hopkins University. The registered enrollment target is 21 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01343316 was terminated before completion, sponsored by Johns Hopkins University.
- TERMINATED
- Registry status
- 21 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the benefit of feeding critically-ill patients beyond the stomach (post-pyloric). Furthermore, because of the advent of two new post-pyloric feeding tubes (Tiger 2 and Syncro BlueTube) designed to improve post-pyloric placement, the investigators will be evaluating the benefits of those two tubes as well.
Primary Outcome
To determine the time to goal calories. To determine the number and qualitative aspect of tracheal aspirations. To determine the time to initiate tube feeds once the decision has been made to place a tube, the number of x-rays required for placement, the time required for placement, the number of times tube needs to be replaced.
Interventions
- DEVICE Transpyloric feeding tubes (Nasogastric Tube (NG tube), Tiger2, Syncro BlueTube)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2010-11 |
| Est. Completion | 2013-03 |
Why NCT01343316 stopped before completion
NCT01343316 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 21 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Transpyloric feeding tubes (Nasogastric Tube (NG tube), Tiger2, Syncro BlueTube) is the first listed.
NCT01343316 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01343316 about?
NCT01343316 is a clinical study titled "Benefits of Post-Pyloric Feeding Tubes in Critically Ill Patients". The purpose of this study is to determine the benefit of feeding critically-ill patients beyond the stomach (post-pyloric). Furthermore, because of the advent of two new post-pyloric feeding tubes (Tiger 2 and Syncro BlueTube) designed to improve post-pyloric placement, the investigators will be eva...
What is the current status of trial NCT01343316?
This trial is currently terminated. The enrollment target is 21 participants. The study started on 2010-11. Estimated completion is 2013-03.
What interventions are being tested in trial NCT01343316?
The interventions under investigation include: Transpyloric feeding tubes (Nasogastric Tube (NG tube), Tiger2, Syncro BlueTube) (DEVICE).
Who is sponsoring clinical trial NCT01343316?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02447874 · 21 participants · Phase 1
Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease
- NCT03826992 · 21 participants · Phase 1
Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia
- NCT04107077 · 21 participants · Phase 2
Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer
- NCT04158635 · 21 participants · Phase 1
Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia